In this episode of 'Conversations in Lung Cancer Research,' host Dr. Rebecca Tay and fellow oncologists A/Prof Surein Arulananda and Dr. Dasantha Jayamanne (DJ) delve into the latest advances in small cell lung cancer treatment.

They explore new first-line treatments, including checkpoint inhibitors and emerging novel agents like lurbinectedin and tarlatamab, highlighting their mechanisms, survival benefits, and toxicity management. The panel also discusses the evolving role of radiotherapy and future directions involving precision medicine and biomarkers. This comprehensive discussion aims to inform clinicians and healthcare professionals about the promising advancements reshaping the small cell lung cancer treatment landscape.

This episode is sponsored by Roche.

TOGA's SCLC Masterclass will take place 20 March 2026, at Novotel on Collins, Melbourne
An advanced workshop covering evolving standards of care and new therapies in SCLC.
Early bird tickets available until 16 Feb 2026 > https://thoraciconcology.org.au/events/masterclass-small-cell-lung-cancer/

RESOURCES AND LINKS:
CREST trial https://pmc.ncbi.nlm.nih.gov/articles/PMC3058352/

Caspian Study https://www.sciencedirect.com/science/article/pii/S1525730425001640

CHEST RT https://trog.com.au/trials/trog-20-01-chest-rt/

DeLLphi-303 https://www.annalsofoncology.org/article/S0923-7534(25)04288-7/fulltext

IMforte https://ascopubs.org/doi/10.1200/JCO.2025.43.16_suppl.8006

Japan study PCI vs MRIhttps://pubmed.ncbi.nlm.nih.gov/28343976/

TIMESTAMPS:

(00:00) Introduction and Acknowledgements

(00:36) Overview of Small Cell Lung Cancer

(02:03) Current First-Line Treatments

(06:59) Radiotherapy in Small Cell Lung Cancer

(11:36) New Developments in Maintenance and Second-Line Treatments

(15:35) Exciting New Therapies and Future Directions

(24:01) Radiotherapy and Immune Engaging Therapies

(32:53) Conclusion and Future Events

KEYWORDS: SCLC, ES-SCLC, Small Cell Lung Cancer, Early Stage Small Cell Lung Cancer

his episode of 'Conversations in Lung Cancer Research' hosted by Dr Alex Davis, features a discussion with Dr. Laird Cameron and Dr. Annie Wong on the current state of lung cancer care and research in New Zealand. The panel explores the challenges and disparities faced by thoracic cancer patients, particularly among the indigenous Māori population. The conversation highlights the differences between patient populations in New Zealand and Australia, the impact of rurality on cancer care, the importance of clinical trials and multinational collaborations, and the future prospects for lung cancer treatments and interventions.

(00:00) Introduction and Acknowledgements

(01:01) Exploring Lung Cancer in New Zealand

(01:13) Meet the Experts: Dr. Laird Cameron and Dr. Annie Wong

(01:48) Challenges in Lung Cancer Diagnosis and Treatment

(02:44) Specialisation Stories: Why Lung Cancer?

(05:20) Comparing Patient Populations: New Zealand vs. Australia

(07:44) Lung Cancer Care Pathways in New Zealand

(09:17) Access to Treatments and Therapies

(14:57) The Role of Lung Cancer Nurses

(18:21) Rural Challenges in Lung Cancer Care

(22:06) Radiology and Diagnostic Delays

(23:08) CTDNA and Liquid Biopsy in New Zealand

(25:03) Strengths and Weaknesses in Lung Cancer Care

(29:29) The Impact of Clinical Trials and TOGA

(33:00) Future Interventions and Wishlists

(39:33) Concluding Thoughts and Farewell

In this episode of Conversations in Lung Cancer Research, hosted by Dr Michael Krasovitsky, a medical oncologist at St. Vincent's Hospital in Sydney, the focus is on lung cancer in older adults. The distinction and application of geriatric oncology are explored through comprehensive discussions with experts: A/Prof Christopher Steer, Prof Shalini Vinod, and Ms Nicole Webb. The conversation delves into the importance of geriatric assessments, the unique challenges faced by older patients undergoing cancer treatment, the impact of ageism, and the necessity of tailored, supportive care. Practical tools and approaches for assessing frailty, treatment decision making, and addressing the stigma surrounding lung cancer and aging are also detailed. The episode underscores the critical need for an open, compassionate, and holistic approach to cancer care in older populations.

(00:00) Introduction and Acknowledgements

(00:58) Meet the Experts

(02:01) Understanding Geriatric Oncology

(03:22) Challenges in Clinical Trials for Older Adults

(06:53) Geriatric Assessment Tools

(10:47) Frailty and Treatment Decisions

(14:21)Quality of Life Considerations

(17:51) Systemic Therapy Considerations

(24:15) Radiotherapy in Older Adults

(29:21) Support Systems and Practical Considerations

(34:56) Addressing Ageism in Cancer Care

(46:19) Stigma and Lung Cancer

(49:28) Conclusion and Final Thoughts

In this episode of Conversations in Lung Cancer Research, host A/Prof Mel Moore interviews Prof Anna Nowak, a renowned medical oncologist, clinical trialist, and tumour immunology researcher. We learn of Anna's early aspirations influenced by her family and mentors, her educational and professional trajectory, and her transition to a leadership role as Deputy Vice Chancellor at the University of Western Australia. Anna shares insights on the challenges and rewards of juggling clinical practice with research, her contributions to mesothelioma studies, involvement in the DREAM and DREAMER trials, and her role in mentoring the next generation of oncologists.

(00:00) Welcome and Acknowledgements

(00:34) Introducing Professor Anna Nowak

(01:50) Anna's Journey into Medicine

(03:18) Transition to Oncology and Research

(05:05) PhD and Early Research Experiences

(09:15) Clinical Trials and Mesothelioma Focus

(24:58) Leadership and Academic Roles

(31:48) Mentorship and Future Aspirations

(32:39) Conclusion and Farewell

n this episode of Conversations in Lung Cancer Research, A/Prof Tim Clay discusses the multidisciplinary management of CNS metastases in the context of thoracic cancers. Joined by Dr. Keryn Davidson, a consultant neurosurgeon, and A/Prof Fiona Hegi Johnson, a radiation oncologist, the discussion focuses on the nuances of treating patients with non-small cell lung cancer presenting with brain metastases. Key topics include the role of neurosurgery, decision-making for radiation therapy, evolving approaches for oncogene-driven cancer patients, management of radiation necrosis, and the complexities of treating small cell lung cancer and leptomeningeal disease.  

This episode is sponsored by Pfizer.

(00:00) Introduction and Acknowledgements

(00:35) Meet the Experts

(01:44) Neurosurgery in CNS Metastases

(07:00) Radiation Therapy Insights

(13:59) Oncogene-Driven Lung Cancer

(25:14) Challenges in Small Cell Lung Cancer

(29:56) Advanced Treatment Strategies

(32:23) Future Directions and Conclusion

In this episode of 'Conversations in Lung Cancer Research,' A/Prof Mel Moore sits down with A/Prof Fiona Hegi Johnson, a radiation oncologist at the Peter McCallum Cancer Center and senior research fellow at the University of Melbourne. Fiona shares her journey into radiation oncology, highlighting her career progression, the impact of serendipity, and the importance of mentors. They discuss technological advancements in the field, the role of multidisciplinary teams, changes in lung cancer treatments, and clinical challenges. Fiona offers insights into balancing clinical work with research and provides advice for early-career professionals in the field.

(00:00) Introduction and Acknowledgements

(00:32) Guest Introduction: Associate Professor Fiona Hegi Johnson

(01:33) Fiona's Career Journey and Early Challenges

(04:08) Choosing Radiation Oncology

(06:04) Balancing Clinical and Academic Roles

(09:46) Challenges in Radiation Oncology Research

(13:45) Technological Advances in Lung Cancer Treatment

(17:22) Multidisciplinary Team Dynamics

(23:03) Fiona's Role in TROG and Mentorship

(28:32) Advice for Early Career Professionals

(30:02) Conclusion and Final Thoughts

In this episode of TOGA's Conversations in Lung Cancer Research, A/Prof Mel Moore speaks with Prof Shankar Siva about his groundbreaking work in radiation oncology, particularly focusing on the PRIME Lung study. They discuss the journey from concept to large clinical trials, the challenges of grant applications, the importance of controversial ideas in research, and the role of industry funding. Shankar also shares insights into his interest in genitourinary cancers and the future of radiation therapy, emphasising the significance of mentorship and practical advice for junior radiation oncologists.

00:00 Welcome and Introduction

00:33 Meet Professor Shankar Siva

01:26 Prime Lung Study Overview

02:32 Building on Previous Research

04:00 From Concept to Large Trial

06:11 International Collaborations

07:16 Tips for Clinician Researchers

12:11 Industry Funding in Radiation Oncology

14:33 Interest in Genitourinary Cancers

19:34 The Role of Mentorship

25:09 Advice for Junior Colleagues

28:25 Conclusion and Final Thoughts

This episode of 'Conversations in Lung Cancer Research' features Dr. Anna McLean, Dr Mark Adams, and Dr Sagun Parakh, discussing research on the microbiome and its influence on lung cancer treatment outcomes. They delve into the differences between the gut and lung microbiomes, methods for studying these microorganisms, and the potential for the microbiome to serve as biomarkers for treatment response and immune-related adverse events. They also cover the importance of collaboration and larger data sets in advancing this promising area of research.

(00:00) Introduction

(01:47) Understanding the Microbiome

(03:40) Gut and Lung Microbiome Relationship

(05:07) Challenges in Lung Microbiome Research

(05:37) Microbiome's Role in Lung Cancer Risk

(06:57) Techniques for Studying the Microbiome

(10:33) Collaborative Efforts in Microbiome Research

(16:09) Potential of Microbiome Modulation

(20:35) Patient Advice and Future Directions

(25:33) Conclusion and Final Thoughts

In this episode of Conversations in Lung Cancer Research, we welcome A/Prof Bryan Chan, a senior Medical Oncologist and this years TOGA ASM Convener. 

Bryan, affiliated with multiple institutions including Adam Crosby Cancer Center and Griffith University, discusses his comprehensive career journey from fellowship at the Princess Margaret Cancer Center in Toronto to his current roles in Australia. The discussion highlights the benefits of overseas fellowships, the development of clinical trials, and his leadership in thoracic oncology at the Sunshine Coast University Hospital. 

Bryan also touches upon the challenges and rewards of balancing private and public practice and pioneering quality improvement initiatives. The episode concludes with an exciting preview of the upcoming TOGA Annual Scientific Meeting, which Bryan is convening. Medical professionals and anyone interested in the latest in lung cancer research and practice will find valuable insights in this conversation with Bryan. 

(00:00) Welcome and Introduction

(00:41) Guest Introduction: Associate Professor Brian Chan

(02:12) Brian's Fellowship Experience at Princess Margaret Cancer Center

(03:44) Benefits of Overseas Fellowships

(06:58) Transitioning Back to Australia

(08:29) Balancing Public and Private Practice

(10:08) Establishing a Quality Committee

(15:02) Building a Clinical Trials Unit

(18:15) Advice for Junior Consultants

(21:19) TOGA Annual Scientific Meeting Preview

(25:39) Conclusion and Farewell

In this episode of Conversations in Lung Cancer Research, A/Prof Mel Moore speaks with Prof Wendy Cooper, a leading pathologist in cancer research. They discuss Wendy's journey into pathology, the evolution of lung cancer diagnostics, the impact of AI and liquid biopsies, and the importance of international collaboration in research. Wendy shares insights on the challenges of equitable access to cancer diagnostics and the pressures faced by pathologists in multidisciplinary meetings. The conversation concludes with advice for junior clinicians on career development and involvement in professional organisations.

(00:00) Introduction and Acknowledgements

(00:36) Introducing Prof Wendy Cooper

(01:32) Wendy's Path to Pathology

(04:42) The Evolution of Lung Cancer Pathology

(08:18) The Role of AI in Pathology

(10:30) Translational Research and International Collaboration

(14:09) Molecular Testing Guidelines in Australia

(18:05) Challenges and Future Directions in Pathology

(26:52) The Impact of Lung Cancer Screening Programs

(29:08) Final Thoughts and Advice